Log in to your Inderes Free account to see all free content on this page.
Acarix
0.275
SEK
-2.48 %
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
2 following
-2.48%
-12.7%
-9.54%
-18.4%
+44.89%
+44.74%
-56.88%
-69.09%
-96.28%
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Read moreMarket cap
292.53M SEK
Turnover
427.19K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
13.2.
2025
Annual report '24
ShowingAll content types
Redeye: Acarix Q3 2024 - Setting the stage for an exciting 2025
Acarix Publishes Third Quarter 2024 Report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio